Skip to main content
. 2021 Feb 15;30:e20. doi: 10.1017/S2045796021000044

Table 1.

Baseline demographic information. All participants were enrolled in the 6-month study between March and October 2019

All participants, N = 1506 Wave 1 group, N = 726 Wave 2 group, N = 780 p-values
Baseline characteristics
Age group, N (%) 0.008
18–39 897 (59.6) 408 (56.2) 489 (62.7)
40–59 540 (35.9) 275 (37.9) 265 (34.0)
⩾60 69 (4.6) 43 (5.9) 26 (3.3)
Gender, N (%) 0.089
Male 560 (37.2) 254 (35.0) 306 (39.2)
Female 946 (62.8) 472 (65.0) 474 (60.8)
Education, N (%) 0.900
Below undergraduate 442 (61.7) 451 (62.1) 487 (62.4)
Undergraduate and above 274 (38.3) 275 (37.5) 293 (37.6)
Occupation, N (%) 0.055
Unemployed 133 (18.9) 162 (22.3) 143 (18.3)
Employed 583 (81.4) 564 (77.7) 637 (81.7)
Marital status, N (%) 0.025
Unmarried 370 (24.6) 156 (21.5) 214 (27.4)
Married 1085 (72.0) 546 (75.2) 539 (69.1)
Divorced or widowed 51 (3.4) 24 (3.3) 27 (3.5)
Birth place, N (%) 0.204
Hubei 159 (10.6) 79 (10.9) 80 (10.3)
Local 121 (8.0) 49 (6.7) 72 (9.2)
Non-local 1226 (81.4) 598 (82.4) 628 (80.5)
Years lived in Shenzhen, N (%) 0.709
5 years and below 440 (29.2) 205 (28.2) 235 (30.1)
5–10 years 251 (16.7) 124 (17.1) 127 (16.3)
10 years and above 815 (54.1) 397 (54.7) 418 (53.6)
Living status, N (%) 0.292
Single 154 (10.2) 75 (10.3) 79 (10.1)
With relatives 1174(78.0) 575 (79.2) 599 (76.8)
With non-relatives 178 (11.8) 76 (10.5) 102 (13.1)
Health status and behaviours
Chronic diseases, N (%) <0.001
No 521 (72.8) 579 (79.8) 540 (69.2)
Yes 195 (27.2) 147 (20.2) 240 (30.8)
Insomnia drug, N (%) 0.901
No 646 (90.2) 652 (89.8) 702 (90.0)
Yes 70 (9.8) 74 (10.2) 78 (10.0)
Referral and see psychologist, N (%) 0.586
No 1306 (86.7) 626 (86.2) 680 (87.2)
Yes 200 (13.3) 100 (13.8) 100 (12.8)
Exercise habit per week (at least 1 time and ⩾30 min), N (%) 0.031
No 854 (56.7) 391 (53.9) 463 (59.4)
Yes 652 (43.3) 335 (46.1) 317 (40.6)
Frequency for smoke in a month, N (%) 0.021
2 days and below 1322 (87.8) 652 (89.8) 670 (85.9)
3 days and above 184 (12.2) 74 (10.2) 110 (14.1)
Frequency for alcohol consumption in a month, N (%) 0.728
2 days and below 1254 (83.3) 692 (82.9) 652 (83.6)
3 days and above 252 (16.7) 124 (17.1) 128 (16.4)
Body-mass index, N (%) 0.525
Normal (18.5–23.9) 945 (62.7) 463 (63.8) 482 (61.8)
Underweight 153 (10.2) 76 (10.5) 77 (9.9)
Overweight 408 (27.1) 187 (25.8) 221 (28.3)

Abbreviation: wave 1: participants completed the baseline and 6-month follow-up before the COVID-19 outbreak (i.e. from March 2019 to January 2020); wave 2: participants completed the baseline before COVID-19 outbreak but 6-month follow-up during the COVID-19 outbreak (i.e. from August 2019 to April 2020).